CYPH Cypherpunk Technologies Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 12, 2026
$3.03
· of 52w range
· above low
· to high
$0.3952w low
$4.1952w high
Market Cap (MRQ)
$327M
P/E
43.3
EPS
$0.07
your badges
52W Range
$0–$4
Analyst Rating
BUY
Price Target
$5
P/E
43.3
ROE
6.1%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
CYPH Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$3.03
Market Cap (MRQ)
$327M
P/E
43.3
EPS
$0.07
ROE
6.1%
52W Range
$0–$4
CYPH Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| June 21, 2023 | 1-for-10 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue·2020-12-31 → 2021-12-31
EPS$0.072017-12-31 → 2025-12-31
Free Cash Flow·2017-12-31 → 2019-12-31
Net margin·2020-12-31 → 2021-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | CYPH | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | 43.35Y avg ≈-11.2 | ≈-11.2 | · | · | |
| P/S | 169.45Y avg ≈476.3 | ≈476.3 | 44.3 | Fair value | |
| P/B (MRQ) | 2.35Y avg ≈7.8 | ≈7.8 | 2.2 | Undervalued | |
| Price / Cash Flow | -5.85Y avg ≈-19.2 | ≈-19.2 | · | · | |
| Price / Tangible Book | 1.75Y avg ≈7.8 | ≈7.8 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | CYPH | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | 4.5%5Y avg ≈-65.0% | ≈-65.0% | -38.1% | Top tier | |
| ROE | 6.1%5Y avg ≈-79.8% | ≈-79.8% | -49.5% | Top tier | |
| ROIC | -12.8%5Y avg ≈-87.4% | ≈-87.4% | -27.0% | Top tier |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | CYPH | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 79.25Y avg ≈12.5 | ≈12.5 | 5.8 | Strong liquidity | |
| Quick Ratio | 3.15Y avg ≈5.9 | ≈5.9 | 4.4 | In line |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
144.8%
Next Report
Nov 10, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 17, 2026 | $0.18 | $-0.03 | 688.2% |
| Sept. 30, 2025 | $-0.08 | $-0.24 | 67.3% | |
| June 30, 2025 | $-0.40 | $-0.30 | -35.2% | |
| March 31, 2025 | $-0.37 | $-0.39 | 4.5% | |
| Dec. 31, 2024 | $-0.37 | $-0.37 | -0.76% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | $2M | $2M | |
| R&D Expense | $26M | $57M | $73M | $45M | $32M | $20M | |
| SG&A Expense | $11M | $13M | $14M | $12M | $11M | $10M | |
| Operating Expenses | $41M | $70M | $87M | $57M | $43M | $30M | |
| Operating Income | $-41M | $-70M | $-87M | $-57M | $-41M | $-29M | |
| Interest Expense | · | · | · | $54.0K | $41.0K | $39.0K | |
| Pretax Income | $10M | $-67M | $-81M | $-54M | $-41M | $-28M | |
| Income Tax | $5M | $585.0K | · | $147.0K | $-24.0K | $-2.0K | |
| Net Income | $5M | $-68M | $-81M | $-55M | $-41M | $-28M | |
| EPS (Basic) | $0.07 | $-1.81 | $-3.98 | $-4.82 | $-0.47 | $-0.63 | |
| EPS (Diluted) | $0.07 | $-1.81 | $-3.98 | $-4.82 | $-0.47 | $-0.63 | |
| Shares (Basic) | 66,140,346 | 37,550,677 | 20,445,109 | 11,323,909 | 85,825,283 | 59,327,713 | |
| Shares (Diluted) | 70,672,358 | 37,550,677 | 20,445,109 | 11,323,909 | 85,825,283 | 59,327,713 | |
| EBITDA | $-41M | $-70M | $-87M | $-57M | $-41M | $-29M |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $14M | $47M | $71M | $66M | $115M | $52M | |
| Prepaid Expense | $40.0K | $86.0K | $183.0K | $351.0K | $769.0K | $130.0K | |
| Current Assets | $162M | $48M | $72M | $68M | $117M | $52M | |
| PP&E (Net) | · | $5.0K | $5.0K | $20.0K | $36.0K | $65.0K | |
| PP&E (Gross) | $226.0K | $226.0K | $226.0K | $226.0K | $226.0K | $226.0K | |
| Accum. Depreciation | $226.0K | $221.0K | $221.0K | $206.0K | $190.0K | $161.0K | |
| Other Non-current Assets | · | · | · | $30.0K | $90.0K | · | |
| Total Assets | $163M | $49M | $73M | $70M | $118M | $54M | |
| Accounts Payable | $2M | $5M | $6M | $6M | $4M | $3M | |
| Accrued Liabilities | $2M | $9M | $6M | $5M | $5M | $3M | |
| Current Liabilities | $5M | $14M | $13M | $11M | $10M | $7M | |
| Capital Leases | · | · | · | $262.0K | $37.0K | $144.0K | |
| Deferred Tax | $5M | · | · | · | · | · | |
| Total Liabilities | $10M | $14M | $13M | $11M | $10M | $8M | |
| Common Stock | $84.0K | $38.0K | $26.0K | $10.0K | $88.0K | $60.0K | |
| Paid-in Capital | $616M | $503M | $460M | $377M | $372M | $270M | |
| Retained Earnings | $-463M | $-467M | $-400M | $-318M | $-264M | $-223M | |
| AOCI | $-95.0K | $-120.0K | $106.0K | $128.0K | $-267.0K | $-579.0K | |
| Stockholders' Equity | $154M | $35M | $60M | $59M | $108M | $47M | |
| Liabilities + Equity | $163M | $49M | $73M | $70M | $118M | $54M | |
| Shares Outstanding | 83,851,051 | 38,329,894 | 25,565,414 | 9,902,137 | 59,657,742 | 59,657,742 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $5M | $6M | $5M | $5M | $4M | $3M | |
| Deferred Tax | $5M | · | · | $147.0K | $13.0K | $-42.0K | |
| Restructuring | $5M | · | · | · | · | · | |
| Operating Cash Flow | $-44M | $-60M | $-44M | $-49M | $-35M | $-26M | |
| Investing Cash Flow | $-97M | · | $49M | · | · | $25.0K | |
| Financing Cash Flow | $108M | $37M | $-30.0K | $-210.0K | $98M | $74M | |
| Net Change in Cash | $-33M | $-23M | $5M | $-49M | $63M | $48M |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | -2761.7% | -1902.6% | |
| Net Margin | · | · | · | · | -2705.8% | -1834.3% | |
| Pretax Margin | · | · | · | · | -2707.4% | -1834.4% | |
| EBITDA Margin | · | · | · | · | -2761.7% | -1902.6% | |
| ROA | 4.5% | -110.8% | -113.7% | -58.0% | -47.1% | -89.0% | |
| ROE | 6.1% | -160.8% | -123.2% | -84.7% | -36.1% | -55.1% | |
| ROIC | -12.8% | -201.6% | · | -96.7% | -38.4% | -61.2% |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 35.6 | 3.4 | 5.6 | 6.1 | 11.7 | 7.1 | |
| Quick Ratio | 3.1 | 3.4 | 5.6 | 5.8 | 11.5 | 7.1 | |
| Interest Coverage | · | · | · | -1051.2 | -1010.4 | -731.8 |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | 0.0 | 0.0 |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.83 | $0.91 | $2.35 | $0.67 | $1.22 | $0.78 | |
| Revenue / Share | · | · | · | · | $0.02 | $0.03 | |
| Cash Flow / Share | $-0.62 | $-1.61 | $-2.14 | $-0.43 | $-0.41 | $-0.44 | |
| Cash / Share | $0.17 | $1.23 | $2.76 | $0.74 | $1.30 | $0.87 | |
| EPS (TTM) | $0.07 | $-1.81 | $-3.98 | $-4.82 | $-0.47 | $-0.63 |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | · | 0.00% | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $2M | $2M | $2M | $2M | $2M | |
| Net Income TTM | $5M | $-68M | $-81M | $-55M | $-41M | $-28M | |
| Market Cap | $97M | $110M | $106M | $397M | $2.86B | $1.34B | |
| P/E | 16.6 | -1.6 | -1.0 | -0.9 | -68.9 | -35.7 | |
| P/S | 64.8 | 73.5 | 70.6 | 265.0 | 1907.7 | 894.9 | |
| P/B | 0.6 | 3.1 | 1.8 | 6.8 | 26.5 | 28.8 | |
| P / Tangible Book | 0.6 | 3.1 | 1.8 | 6.8 | 26.5 | 28.8 | |
| P / Cash Flow | -2.2 | -1.8 | -2.4 | -8.1 | -81.4 | -51.7 | |
| Earnings Yield | 6.0% | -63.0% | -96.0% | -107.1% | -1.5% | -2.8% |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $197.0K | $161.0K | $975.0K | $1M | $11M | $13M | $13M | $15M | $18M | $11M | $12M | $12M | $11M | $39M | $11M | $12M | |
| SG&A Expense | $4M | $5M | $4M | $2M | $2M | $3M | $3M | $3M | $3M | $4M | $3M | $3M | $4M | $4M | $3M | $3M | |
| Operating Expenses | $5M | $5M | $5M | $3M | $17M | $16M | $16M | $18M | $21M | $15M | $15M | $15M | $15M | $43M | $14M | $15M | |
| Operating Income | $-5M | $-5M | $-5M | $-3M | $-17M | $-16M | $-16M | $-18M | $-21M | $-15M | $-15M | $-15M | $-15M | $-43M | $-14M | $-15M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $5.0K | $11.0K | |
| Pretax Income | $41M | $-82M | $45M | $-3M | $-17M | $-15M | $-16M | $-17M | · | · | $-12M | $-14M | · | · | · | · | |
| Income Tax | $2M | $-5M | $5M | $202.0K | · | · | $-123.0K | $708.0K | · | · | · | · | · | · | · | · | |
| Net Income | $39M | $-77M | $40M | $-3M | $-17M | $-15M | $-15M | $-18M | $-20M | $-14M | $-12M | $-14M | $-13M | $-42M | $-12M | $-15M | |
| EPS (Basic) | $0.21 | $-0.46 | $0.92 | $-0.08 | $-0.40 | $-0.37 | $-0.34 | $-0.44 | $-0.52 | $-0.51 | $0.68 | $-0.51 | $-0.91 | $-3.24 | $-1.90 | $-1.33 | |
| EPS (Diluted) | $0.18 | $-0.46 | $0.92 | $-0.08 | $-0.40 | $-0.37 | $-0.34 | $-0.44 | $-0.52 | $-0.51 | $0.68 | $-0.51 | $-0.91 | $-3.24 | $-1.90 | $-1.33 | |
| Shares (Basic) | 184,328,441 | 168,103,535 | · | 41,444,979 | 41,444,979 | 41,268,894 | · | 41,209,639 | 39,122,662 | 27,014,100 | · | 26,987,182 | 14,710,375 | 12,934,427 | · | 11,323,909 | |
| Shares (Diluted) | 217,343,013 | 168,103,535 | · | 41,444,979 | 41,444,979 | 41,268,894 | · | 41,209,639 | 39,122,662 | 27,014,100 | · | 26,987,182 | 14,710,375 | 12,934,427 | · | 11,323,909 | |
| EBITDA | $-5M | $-5M | · | $-3M | $-17M | $-16M | · | $-18M | $-21M | $-15M | · | $-15M | $-15M | $-43M | · | $-15M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8M | $7M | $14M | $10M | $18M | $33M | $47M | $63M | $78M | $55M | $71M | $81M | $91M | $102M | $66M | $78M | |
| Prepaid Expense | $539.0K | $768.0K | $40.0K | $69.0K | $292.0K | $446.0K | $86.0K | $209.0K | $354.0K | $526.0K | $183.0K | $265.0K | $419.0K | $590.0K | $351.0K | $374.0K | |
| Current Assets | $138M | $82M | $162M | $10M | $19M | $34M | $48M | $64M | $80M | $56M | $72M | $82M | $94M | $105M | $68M | $80M | |
| PP&E (Net) | · | · | · | · | · | · | $5.0K | · | · | · | $5.0K | $9.0K | $13.0K | $16.0K | $20.0K | $24.0K | |
| PP&E (Gross) | · | · | $226.0K | · | · | · | $226.0K | · | · | · | $226.0K | · | · | · | $226.0K | · | |
| Accum. Depreciation | · | · | $226.0K | · | · | · | $221.0K | · | · | · | $221.0K | · | · | · | $206.0K | · | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | · | · | · | $15.0K | $30.0K | $45.0K | |
| Total Assets | $143M | $87M | $163M | $11M | $20M | $35M | $49M | $65M | $81M | $58M | $73M | $83M | $96M | $107M | $70M | $82M | |
| Accounts Payable | $588.0K | $516.0K | $2M | $4M | $7M | $6M | $5M | $6M | $8M | $6M | $6M | $6M | $6M | $5M | $6M | $6M | |
| Accrued Liabilities | $1M | $2M | $2M | $4M | $7M | $7M | $9M | $9M | $7M | $4M | $6M | $5M | $5M | $4M | $5M | $5M | |
| Current Liabilities | $2M | $3M | $5M | $9M | $14M | $14M | $14M | $16M | $16M | $10M | $13M | $11M | $12M | $10M | $11M | $12M | |
| Capital Leases | · | · | · | · | · | · | · | · | $39.0K | $154.0K | · | · | $38.0K | $152.0K | $262.0K | $369.0K | |
| Deferred Tax | $2M | · | $5M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $4M | $3M | $10M | $9M | · | · | $14M | $16M | $16M | $11M | · | $11M | $12M | $11M | $11M | $12M | |
| Common Stock | $108.0K | $94.0K | $84.0K | $41.0K | $41.0K | $41.0K | $38.0K | $38.0K | $38.0K | $26.0K | $26.0K | $26.0K | $26.0K | $119.0K | $10.0K | $99.0K | |
| Paid-in Capital | $640M | $624M | $616M | $506M | $505M | $504M | $503M | $501M | $500M | $461M | $460M | $458M | $457M | $388M | $377M | $375M | |
| Retained Earnings | $-500M | $-540M | $-463M | $-503M | $-499M | $-483M | $-467M | $-452M | $-434M | $-413M | $-400M | $-387M | $-373M | $-360M | $-318M | $-306M | |
| AOCI | $-81.0K | $-86.0K | $-95.0K | $-104.0K | $-82.0K | $-113.0K | $-120.0K | $6.0K | $3.0K | $-120.0K | $106.0K | $760.0K | $414.0K | $355.0K | $128.0K | $690.0K | |
| Stockholders' Equity | $139M | $84M | $154M | $3M | $6M | $21M | $35M | $49M | $66M | $47M | $60M | $72M | $84M | $28M | $59M | $70M | |
| Liabilities + Equity | $143M | $87M | $163M | $11M | $20M | $35M | $49M | $65M | $81M | $58M | $73M | $83M | $96M | $107M | $70M | $82M | |
| Shares Outstanding | 107,764,382 | 93,927,528 | 83,851,051 | 41,439,529 | 41,439,529 | 41,439,529 | 38,329,894 | 38,264,464 | 38,264,464 | 25,603,417 | 25,565,414 | 25,565,414 | 25,565,414 | 119,410,992 | 9,902,137 | 99,021,376 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $2M | $2M | $303.0K | $1M | $1M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Deferred Tax | $2M | $-5M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Restructuring | · | · | $0 | $0 | $5M | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-3M | $-3M | $-7M | $-8M | $-14M | $-14M | $-16M | $-16M | $-14M | $-16M | $-10M | $-10M | $-10M | $-13M | $-13M | $-12M | |
| Investing Cash Flow | $-10M | $-9M | · | · | · | · | · | · | · | · | $0 | $0 | $-348.0K | $49M | · | · | |
| Financing Cash Flow | $13M | $5M | $108M | $-121.0K | $-119.0K | $-61.0K | $104.0K | $-66.0K | $37M | $29.0K | $0 | $-1.0K | $0 | $-29.0K | $0 | $0 | |
| Net Change in Cash | $935.0K | $-7M | $4M | $-8M | $-15M | $-15M | $-16M | $-16M | $24M | $-16M | $-10M | $-11M | $-11M | $37M | $-13M | $-13M |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | 48.3% | -126.2% | · | -8.6% | -32.8% | -33.2% | · | -24.6% | -22.7% | -16.8% | · | -16.6% | -14.1% | -39.4% | · | -14.4% | |
| ROE | 54.3% | -146.7% | · | -12.8% | -46.6% | -45.3% | · | -30.0% | -26.9% | -36.5% | · | -19.3% | -16.0% | -66.0% | · | -16.2% | |
| ROIC | -3.2% | -5.3% | · | -125.1% | · | · | · | -38.0% | · | · | · | · | · | · | · | · |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 79.2 | 27.3 | · | 1.2 | 1.3 | 2.4 | · | 4.0 | 5.1 | 5.4 | · | 7.4 | 8.0 | 10.2 | · | 6.8 | |
| Quick Ratio | 4.4 | 2.2 | · | 1.1 | 1.3 | 2.3 | · | 3.9 | 5.0 | 5.3 | · | 7.3 | 7.8 | 9.9 | · | 6.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -1389.8 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.29 | $0.90 | · | $0.07 | $0.14 | $0.50 | · | $1.28 | $1.72 | $1.85 | · | $2.82 | $3.29 | $0.24 | · | $0.71 | |
| Cash Flow / Share | · | $-0.02 | · | · | · | $-0.35 | · | · | · | $-0.57 | · | · | · | $-0.10 | · | · | |
| Cash / Share | $0.07 | $0.07 | · | $0.23 | $0.44 | $0.79 | · | $1.64 | $2.05 | $2.15 | · | $3.16 | $3.58 | $0.85 | · | $0.79 | |
| EPS (TTM) | $0.56 | $-0.02 | · | $-1.19 | $-1.55 | $-1.67 | · | $-0.79 | $-0.86 | $-1.25 | · | $-6.56 | $-7.38 | $-7.97 | · | $-3.01 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $2M | · | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $2M | |
| Net Income TTM | $-877.0K | $-57M | · | $-51M | $-66M | $-69M | · | $-65M | $-60M | $-53M | · | $-81M | $-82M | $-86M | · | $-53M | |
| Market Cap | $66M | $75M | · | $19M | $12M | $13M | · | $98M | $75M | $68M | · | $35M | $80M | $406M | · | $871M | |
| P/E | 1.1 | -39.8 | · | -0.4 | -0.2 | -0.2 | · | -3.3 | -2.3 | -2.1 | · | -0.2 | -0.4 | -0.4 | · | -2.9 | |
| P/S | 44.0 | 49.8 | · | 12.5 | 8.2 | 8.4 | · | 65.6 | 50.0 | 45.4 | · | 23.5 | 53.3 | 270.7 | · | 580.9 | |
| P/B | 0.5 | 0.9 | · | 7.0 | 2.2 | 0.6 | · | 2.0 | 1.1 | 1.4 | · | 0.5 | 1.0 | 14.3 | · | 12.4 | |
| P / Tangible Book | 0.5 | 0.9 | · | 7.0 | 2.2 | 0.6 | · | 2.0 | 1.1 | 1.4 | · | 0.5 | 1.0 | 14.3 | · | 12.4 | |
| P / Cash Flow | · | -21.8 | · | · | · | -0.9 | · | · | · | -4.4 | · | · | · | -32.0 | · | · | |
| Earnings Yield | 91.5% | -2.5% | · | -262.1% | -521.9% | -547.5% | · | -30.7% | -43.9% | -47.0% | · | -475.4% | -235.8% | -234.4% | · | -34.2% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | · | · | · | · | $2M |
| Operating Margin % | · | · | · | · | -2761.7% |
| Net Income | $5M | $-68M | $-81M | $-55M | $-41M |
| Diluted EPS | $0.07 | $-1.81 | $-3.98 | $-4.82 | $-0.47 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 35.6 | 3.4 | 5.6 | 6.1 | 11.7 |
| Quick Ratio | 3.1 | 3.4 | 5.6 | 5.8 | 11.5 |
No data for this statement
Not enough fundamentals data to build this statement yet.
Institutional owners (13F) 57 filers · $12.4M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
57
Value held
$12.4M
New positions
13
Exited positions
5
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 13 (-2 vs prior Q) | 5 (-3 vs prior Q) | 21 (+13 vs prior Q) | 8 (-2 vs prior Q) | +7.8M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| VANGUARD GROUP INC | $2,467,446 | 2,127,109 | 19.97% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $2,379,195 | 3,887,574 | 19.26% | Shares |
| BlackRock, Inc. | $1,605,955 | 2,622,823 | 13.00% | Shares |
| JANE STREET GROUP, LLC | $1,042,089 | 1,701,926 | 8.43% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $718,804 | 1,173,737 | 5.82% | Shares |
| UBS Group AG | $689,948 | 1,127,366 | 5.58% | Shares |
| CITADEL ADVISORS LLC | $511,976 | 836,153 | 4.14% | Shares |
| XTX Topco Ltd | $390,849 | 638,329 | 3.16% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $355,752 | 583,200 | 2.88% | Call option |
| VANGUARD FIDUCIARY TRUST CO | $349,663 | 571,345 | 2.83% | Shares |
| STATE STREET CORP | $316,016 | 516,113 | 2.56% | Shares |
| CITADEL ADVISORS LLC | $259,003 | 423,000 | 2.10% | Call option |
| NORTHERN TRUST CORP | $135,950 | 222,031 | 1.10% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $133,479 | 217,997 | 1.08% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $123,220 | 202,000 | 1.00% | Put option |
| JANE STREET GROUP, LLC | $107,826 | 176,100 | 0.87% | Call option |
| MORGAN STANLEY | $106,900 | 174,586 | 0.87% | Shares |
| LPL Financial LLC | $97,474 | 159,194 | 0.79% | Shares |
| Sequoia Financial Advisors, LLC | $93,376 | 152,500 | 0.76% | Shares |
| HighTower Advisors, LLC | $61,585 | 100,580 | 0.50% | Shares |
| JANE STREET GROUP, LLC | $53,637 | 87,600 | 0.43% | Put option |
| TWO SIGMA INVESTMENTS, LP | $49,236 | 80,411 | 0.40% | Shares |
| Key Client Fiduciary Advisors, LLC | $45,985 | 75,102 | 0.37% | Shares |
| Toroso Investments, LLC | $40,964 | 35,314 | 0.33% | Shares |
| Farther Finance Advisors, LLC | $27,458 | 44,844 | 0.22% | Shares |
| Texas Capital Bank Wealth Management Services Inc | $23,022 | 37,600 | 0.19% | Shares |
| Simplify Asset Management Inc. | $17,132 | 27,979 | 0.14% | Shares |
| CITADEL ADVISORS LLC | $16,716 | 27,300 | 0.14% | Put option |
| Spark Investment Management LLC | $15,859 | 25,900 | 0.13% | Shares |
| Gerber Kawasaki Wealth & Investment Management | $13,470 | 22,000 | 0.11% | Shares |
| GROUP ONE TRADING LLC | $13,130 | 21,444 | 0.11% | Shares |
| Qube Research & Technologies Ltd | $9,639 | 15,742 | 0.08% | Shares |
| Tower Research Capital LLC (TRC) | $8,972 | 14,653 | 0.07% | Shares |
| BARCLAYS PLC | $8,463 | 13,821 | 0.07% | Shares |
| Keystone Financial Group | $7,172 | 11,712 | 0.06% | Shares |
| Vanguard Global Advisers, LLC | $7,105 | 11,609 | 0.06% | Shares |
| SIMON QUICK ADVISORS, LLC | $6,958 | 11,364 | 0.06% | Shares |
| Quadrant Private Wealth Management, LLC | $6,858 | 11,200 | 0.06% | Shares |
| IHT Wealth Management, LLC | $6,735 | 11,000 | 0.05% | Shares |
| Key Client Fiduciary Advisors, LLC | $6,735 | 11,000 | 0.05% | Call option |
| Scientech Research LLC | $6,238 | 10,187 | 0.05% | Shares |
| BLAIR WILLIAM & CO/IL | $6,123 | 10,000 | 0.05% | Shares |
| ADIRONDACK TRUST CO | $6,100 | 10,000 | 0.05% | Shares |
| SIMPLEX TRADING, LLC | $2,709 | 4,427 | 0.02% | Shares |
| OSAIC HOLDINGS, INC. | $1,128 | 1,850 | 0.01% | Shares |
| HUNTINGTON NATIONAL BANK | $612 | 1,000 | 0.00% | Shares |
| SBI Securities Co., Ltd. | $431 | 704 | 0.00% | Shares |
| Cygnus Capital Advisors, LLC | $151 | 246,460 | 0.00% | Shares |
| JPMORGAN CHASE & CO | $144 | 227 | 0.00% | Shares |
| Allworth Financial LP | $83 | 135 | 0.00% | Shares |
Activists & 5%+ owners 5 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Cameron Howard Winklevoss, Tyler Howard Winklevoss, Winklevoss Capital Fund, LLC, Winklevoss Capital Management, LLC, Winklevoss Treasury Investments, LLC | Aug. 19, 2026 | 19.90% | Amendment | · | SEC |
| Winklevoss Capital Fund, LLC, Winklevoss Treasury Investments, LLC, Winklevoss Capital Management, LLC, Tyler Howard Winklevoss, Cameron Howard Winklevoss ×2 filings | Nov. 21, 2025 | 19.90% | Amendment | · | SEC |
| BeiGene, Ltd. ×4 filings | Oct. 31, 2024 | 0.00% | Amendment | · | SEC |
| Valence Helix Investments III, LLC, Valence Helix Investments, LLC, Eric Roberts, Graham Crooke, Rachel Leheny, Philip Sawyer, Evgeny Zaytsev ×2 filings | Jan. 21, 2020 | · | Initial filing | · | SEC |
| HealthCare Ventures IX, L.P., HealthCare Partners IX, L.P., HealthCare Partners IX, LLC, HealthCare Ventures VIII, L.P., HealthCare Partners VIII, L.P., HealthCare Partners VIII, LLC, HealthCare Ventures Strategic Fund, L.P., HealthCare Strategic Partners, LLC, Christopher Mirabelli, Augustine Lawlor, Douglas E. Onsi, James H. Cavanaugh, John W. Littlechild, Harold Werner ×4 filings | Feb. 8, 2019 | · | Initial filing | Capital structure | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 23 insiders · 8 officers · 13 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Douglas E Onsi | CEO,CFO,Pres.,GC,Treas.&Sec. | July 1, 2026 A | 106,858 | 0 | 2 | $-2,123,642 |
| Augustine Lawlor | Chief Operating Officer | March 28, 2025 M | 19,789 | 0 | 0 | $0 |
| Kevin Zhang | Head of Mining | Aug. 21, 2026 A | · | 0 | 0 | $0 |
| William Patrick Mcevoy III | Chief Investment Officer | Aug. 17, 2026 J | 24,854,613 | 0 | 0 | $0 |
| Jason Baum | Chief Scientific Officer | March 28, 2025 M | 15,896 | 0 | 0 | $0 |
| Christine Granfield | VP, Head of Reg Affairs/Qual | March 28, 2025 M | 15,896 | 0 | 0 | $0 |
| John Mark O'Mahony | Chief Manufacturing Officer | March 28, 2025 M | 27,500 | 0 | 0 | $0 |
| Cynthia Sirard | Chief Medical Officer | March 28, 2025 M | 27,500 | 0 | 0 | $0 |
| Khing Djien Oei | Director | Sept. 25, 2026 S | 0 | 0 | 1 | $-661,500 |
| Patricia A. Martin | Director | Sept. 23, 2026 S | 118,750 | 0 | 1 | $-193,000 |
| Thomas John Dietz | Director | Aug. 26, 2026 S | 132,500 | 0 | 1 | $-34,400 |
| Christian M Richard | Director | July 1, 2026 A | 168,750 | 0 | 0 | $0 |
| Nissim Mashiach | Director | July 1, 2026 A | 168,750 | 0 | 0 | $0 |
| William Li | Director | July 1, 2026 A | 168,750 | 0 | 0 | $0 |
| Christopher Mirabelli | Director | March 26, 2026 S | 130,376 | 0 | 3 | $-2,166,242 |
| Richard Schilsky | Director | March 13, 2026 M | 168,750 | 0 | 0 | $0 |
| Joseph Loscalzo | Director | March 13, 2026 M | 168,750 | 0 | 0 | $0 |
| CAVANAUGH JAMES H | Director | March 13, 2026 M | 168,963 | 0 | 1 | $-822,178 |
| John W Littlechild | Director | March 2, 2020 A | · | 0 | 0 | $0 |
| BeiGene, Ltd. | 10% owner | Sept. 24, 2021 P | 7,348,437 | 0 | 0 | $0 |
| Harold R Werner | 10% owner | July 30, 2018 J | · | 0 | 0 | $0 |
| Eli Lilly and Company | 10% owner | July 30, 2018 A | · | 0 | 0 | $0 |
| Monica Bertagnolli | · | Jan. 31, 2022 A | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 2 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
CYPH Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 7 analysts
BUY
Median target
$4.90
+61.7%
2 28.6%
Strong Buy
4 57.1%
Buy
1 14.3%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
1 analysts · 2026-10-02Mean target $4.90 +61.7%
Low$4.90
Mean$4.90
High$4.90
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| CYPH | $97M | 16.6 | · | · | 6.1% | · |
| FENC | $263M | -22.6 | -6.1% | -21.8% | -69.6% | · |
| ZNTL | $93M | -0.7 | · | · | -49.5% | · |
| OCGN | $422M | -5.6 | 8.8% | -1537.4% | 1488.8% | · |
| INDP | $6M | -0.1 | · | · | -2820.8% | · |
| SRZN | · | · | · | · | · | · |
| ARTV | · | -1.3 | -99.2% | · | · | · |
| SCTX | · | · | · | · | · | · |
| BNTC | $460M | -13.7 | · | · | -25.0% | · |
| EBS | $644M | 13.3 | -28.8% | 7.1% | 9.9% | · |
| BBOT | $1.00B | -2.9 | · | · | -146.2% | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 12, 2026